PHARMENA SA

  • Market Cap: N/A
  • Industry: FMCG
  • ISIN: PLPHRMN00011
PLN
2.97
-0.03 (-1.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About PHARMENA SA stock-summary
stock-summary
PHARMENA SA
FMCG
Pharmena SA is a Poland-based producer of cosmetics and pharmaceuticals. The Company’s products range encompasses Dermena, a line of products against hair loss; Dermena Plus, a shampoo reducing the symptoms of dandruff and preventing excessive hair loss; Accos, an anti-acne gel; Allerco, a line of hypo-allergic emollients for body care, Thermi, a gel after thermal burn and sunburn; and Revium, a line of anti-wrinkle treatment products. Pharmena SA maintains multidirectional research works and application studies in conjunction with a number of research centers in Europe, the United States and Canada. As of December 31, 2011, the Company had one wholly owned subsidiary, Cortria Corporation, based in the United States. As of December 31, 2011, Polska Grupa Farmaceutyczna SA held a 43.65% stake in the capital. The main shareholder of the Company is Pelion SA.
Company Coordinates stock-summary
Company Details
Ul. Wolczanska 178 , LODZ None : 90-530
stock-summary
Tel: 48 42 291337048 502 258387
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Prof. Dr. Jerzy Gebicki
Chairman of the Supervisory Board
Dr. Jan Adamus
Member of the Supervisory Board
Mr. Jacek Dauenhauer
Member of the Supervisory Board
Ms. Agnieszka Dziki
Member of the Supervisory Board
Mr. Zbigniew Molenda
Member of the Supervisory Board
Prof. Anna Sysa-Jedrzejowska
Member of the Supervisory Board
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Sep 2024)
Net Profit:
0 Million
stock-summary
Industry

FMCG

stock-summary
Market cap

PLN 34 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.91

stock-summary
Return on Equity

-14.34%

stock-summary
Price to Book

2.86